UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Induction of SREBP1 degradation coupled with suppression of SREBP1-mediated lipogenesis impacts the response of EGFR mutant NSCLC cells to osimertinib

Oncogene, 2021-12, Vol.40 (49), p.6653-6665

2021

Volltextzugriff (PDF)

ALK inhibitors downregulate the expression of death receptor 4 in ALK-mutant lung cancer cells via facilitating Fra-1 and c-Jun degradation and subsequent AP-1 suppression

Neoplasia (New York, N.Y.), 2023-08, Vol.42, p.100908-100908, Article 100908

2023

Volltextzugriff (PDF)

Inhibition of MEK5/ERK5 signaling overcomes acquired resistance to the third generation EGFR inhibitor, osimertinib, via enhancing Bim-dependent apoptosis

Cancer letters, 2021-10, Vol.519, p.141-149

2021

Volltextzugriff (PDF)

Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes

Open medicine (Warsaw, Poland), 2023-09, Vol.18 (1), p.20230690-20230690

2023

Volltextzugriff (PDF)

Resistance mechanisms to osimertinib and emerging therapeutic strategies in nonsmall cell lung cancer

Current opinion in oncology, 2022-01, Vol.34 (1), p.54-65

2022

Volltextzugriff (PDF)

Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer

Acta biomaterialia, 2021-07, Vol.129, p.258-268

2021

Volltextzugriff (PDF)

Effectiveness and safety analysis of serplulimab-based regimens in patients with HER2-negative advanced gastric cancer from a real-world retrospective study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e16058-e16058

2024

Volltextzugriff (PDF)

CPSF6-mediated XBP1 3’UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma

Drug resistance updates, 2023-05, Vol.68, p.100933-100933, Article 100933

2023

Volltextzugriff (PDF)

Do buy-side analysts in earnings conference calls manipulate stock prices?

Journal of corporate finance (Amsterdam, Netherlands), 2024-12, Vol.89, p.102652, Article 102652

2024

Volltextzugriff (PDF)

Abstract 4864: ALK inhibitors downregulate the expression of death receptor 4 in ALK-mutant NSCLC cells via facilitating Fra-1 and c-Jun degradation and subsequent AP-1 suppression

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4864-4864

2023

Volltextzugriff (PDF)

Catastrophic risk and institutional investors: Evidence from institutional trading around 9/11

Pacific-Basin finance journal, 2019-09, Vol.56, p.211-233

2019

Volltextzugriff (PDF)

CAFR 1999–2021, the past two decades and a look ahead

Journal of financial stability, 2022-06, Vol.60, p.101015, Article 101015

2022

Volltextzugriff (PDF)

Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers

Journal for immunotherapy of cancer, 2021-12, Vol.9 (12), p.e003773

2021

Volltextzugriff (PDF)

Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling

Lung cancer (Auckland), 2021-01, Vol.12, p.1-10

2021

Volltextzugriff (PDF)

The novel MET inhibitor, HQP8361, possesses single agent activity and enhances therapeutic efficacy of AZD9291 (osimertinib) against AZD9291-resistant NSCLC cells with activated MET

American journal of cancer research, 2020-01, Vol.10 (10), p.3316-3327

2020

Volltextzugriff (PDF)

FFRDV: Fastest-Ferry Routing in DTN-enabled Vehicular Ad Hoc Networks

2009 11th International Conference on Advanced Communication Technology, 2009, Vol.2, p.1410-1414

2009

Volltextzugriff (PDF)

Do Buy-Side Analysts in Earnings Conference Calls Manipulate Stock Prices?

SSRN Electronic Journal, 2024

2024

Volltextzugriff (PDF)

CAFR 1999-2019, Past Two Decades and Looking Ahead

SSRN Electronic Journal

Volltextzugriff (PDF)

(VVOF)velocity vector-based opportunistic forwarding in vehicular sensor network

2009 9th International Symposium on Communications and Information Technology, 2009, p.627-628

2009

Volltextzugriff (PDF)

The Role of Institutional Investors During Catastrophic Events: Evidence from Institutional Trading Around 9/11

SSRN Electronic Journal

Volltextzugriff (PDF)

Fisetin Attenuates Doxorubicin-Induced Cardiomyopathy In Vivo and In Vitro by Inhibiting Ferroptosis Through SIRT1/Nrf2 Signaling Pathway Activation

Frontiers in pharmacology, 2022-02, Vol.12, p.808480-808480

2022

Volltextzugriff (PDF)

Covalent Organic Polymers Based on Fluorinated Porphyrin as Oxygen Nanoshuttles for Tumor Hypoxia Relief and Enhanced Photodynamic Therapy

Advanced functional materials, 2018-10, Vol.28 (43), p.n/a

2018

Volltextzugriff (PDF)

Thermo-responsive chitosan/silk fibroin/amino-functionalized mesoporous silica hydrogels with strong and elastic characteristics for bone tissue engineering

International journal of biological macromolecules, 2021-07, Vol.182, p.1746-1758

2021

Volltextzugriff (PDF)

Near-infrared light activation of quenched liposomal Ce6 for synergistic cancer phototherapy with effective skin protection

Biomaterials, 2017-05, Vol.127, p.13-24

2017

Volltextzugriff (PDF)

Mechanically interlocked [c2]daisy chain backbone enabling advanced shape-memory polymeric materials

Nature communications, 2024-02, Vol.15 (1), p.1690-1690, Article 1690

2024

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(102)
Tagungsberichte
(8)

Sprache

Englisch
(109)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(53)
Humans
(28)
Technology
(24)
Physical Sciences
(16)
Chemistry
(12)
Computer Science
(12)
Animals
(11)
Male
(11)
Materials Science
(11)
Female
(10)
Apoptosis
(9)
Mutation
(9)
Patients
(9)
Materials Science, Multidisciplinary
(8)
Oncology
(8)
Biochemistry & Molecular Biology
(7)
Immunology
(7)
Proteins
(7)
Chemistry, Multidisciplinary
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Induction of SREBP1 degradation coupled with suppression of SREBP1-mediated lipogenesis impacts the response of EGFR mutant NSCLC cells to osimertinib

ALK inhibitors downregulate the expression of death receptor 4 in ALK-mutant lung cancer cells via facilitating Fra-1 and c-Jun degradation and subsequent AP-1 suppression

Inhibition of MEK5/ERK5 signaling overcomes acquired resistance to the third generation EGFR inhibitor, osimertinib, via enhancing Bim-dependent apoptosis

Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes

Resistance mechanisms to osimertinib and emerging therapeutic strategies in nonsmall cell lung cancer

Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer

Effectiveness and safety analysis of serplulimab-based regimens in patients with HER2-negative advanced gastric cancer from a real-world retrospective study

CPSF6-mediated XBP1 3’UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma

Do buy-side analysts in earnings conference calls manipulate stock prices?

Abstract 4864: ALK inhibitors downregulate the expression of death receptor 4 in ALK-mutant NSCLC cells via facilitating Fra-1 and c-Jun degradation and subsequent AP-1 suppression

Catastrophic risk and institutional investors: Evidence from institutional trading around 9/11

CAFR 1999–2021, the past two decades and a look ahead

Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers

Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling

The novel MET inhibitor, HQP8361, possesses single agent activity and enhances therapeutic efficacy of AZD9291 (osimertinib) against AZD9291-resistant NSCLC cells with activated MET

FFRDV: Fastest-Ferry Routing in DTN-enabled Vehicular Ad Hoc Networks

Do Buy-Side Analysts in Earnings Conference Calls Manipulate Stock Prices?

CAFR 1999-2019, Past Two Decades and Looking Ahead

(VVOF)velocity vector-based opportunistic forwarding in vehicular sensor network

The Role of Institutional Investors During Catastrophic Events: Evidence from Institutional Trading Around 9/11

Fisetin Attenuates Doxorubicin-Induced Cardiomyopathy In Vivo and In Vitro by Inhibiting Ferroptosis Through SIRT1/Nrf2 Signaling Pathway Activation

Covalent Organic Polymers Based on Fluorinated Porphyrin as Oxygen Nanoshuttles for Tumor Hypoxia Relief and Enhanced Photodynamic Therapy

Thermo-responsive chitosan/silk fibroin/amino-functionalized mesoporous silica hydrogels with strong and elastic characteristics for bone tissue engineering

Near-infrared light activation of quenched liposomal Ce6 for synergistic cancer phototherapy with effective skin protection

Mechanically interlocked [c2]daisy chain backbone enabling advanced shape-memory polymeric materials

Suchergebnisse filtern